Within a span of nine days, more than 160 patients have been hospitalized for adverse reactions to synthetic cannabinoid, known as “spice” or “K2” — which are legal plant material coated with chemicals that supposedly mimic the effects of marijuana — according to a statement from Gov. Andrew Cuomo’s office.
Symptoms hospitalized patients have reported include confusion, drowsiness, headaches, increased heart rate, seizures and loss of consciousness.
The New York State Department of Health noted the synthetic marijuana is popular particularly among teenagers.
Alabama and Mississippi health officials have also reported similar trends with numerous synthetic marijuana-related hospitalizations.
More articles on marijuana:
Despite changing public opinion, pediatricians still oppose legalizing marijuana
Colorado to spend more than $8M researching health benefits of medical marijuana
Uptick in ED visits related to synthetic drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
